Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,029 | -35,374 | -23,887 | -12,017 | -6,211 |
| Depreciation Amortization | 705 | 2,472 | 1,773 | 1,028 | 405 |
| Income taxes - deferred | 3 | 8 | 8 | 5 | 0 |
| Accounts receivable | 270 | 1,131 | 1,469 | 1,244 | 1,665 |
| Accounts payable and accrued liabilities | 246 | 2,944 | 749 | -850 | -567 |
| Other Working Capital | 7,260 | -248 | -921 | -2,648 | -991 |
| Other Operating Activity | 2,005 | 1,652 | 1,563 | 1,758 | 330 |
| Operating Cash Flow | $-5,540 | $-27,415 | $-19,246 | $-11,480 | $-5,369 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,906 | -128,151 | -78,303 | -79,963 | -51,788 |
| PPE Investments | -327 | -1,594 | -1,412 | -1,049 | -255 |
| Other Investing Activity | 0 | -817 | 0 | 0 | 0 |
| Investing Cash Flow | $13,579 | $-130,562 | $-79,715 | $-81,012 | $-52,043 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3,067 | -3,027 | -718 | -356 |
| Common Stock Issued | 48 | 82,040 | 128 | 9 | 0 |
| Other Financing Activity | -12 | 74,430 | 73,655 | 74,647 | 1,191 |
| Financing Cash Flow | $36 | $153,403 | $70,756 | $73,938 | $835 |
| Beginning Cash Position | 59,822 | 64,396 | 64,396 | 64,396 | 64,396 |
| End Cash Position | 67,897 | 59,822 | 36,191 | 45,842 | 7,819 |
| Net Cash Flow | $8,075 | $-4,574 | $-28,205 | $-18,554 | $-56,577 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,540 | -27,415 | -19,246 | -11,480 | -5,369 |
| Capital Expenditure | -327 | -1,594 | -1,412 | -1,049 | -255 |
| Free Cash Flow | -5,867 | -29,009 | -20,658 | -12,529 | -5,624 |